Predictive value of radiological response, pathological response and relapse-free survival for overall survival in neoadjuvant immunotherapy trials: pooled analysis of 29 clinical trials.

Nie, Runcong; Chen, Foping; Provencio, Mariano; Wang, Yun; van den Ende, Tom; van Laarhoven, Hanneke W M; Yuan, Shuqiang; Pless, Miklos; Hayoz, Stefanie; Zhou, Zhiwei; Li, Yuanfang; Rothschild, Sacha I; Cai, Muyan

Nie, Runcong; Chen, Foping; Provencio, Mariano; Wang, Yun; van den Ende, Tom; van Laarhoven, Hanneke W M; Yuan, Shuqiang; Pless, Miklos; Hayoz, Stefanie; Zhou, Zhiwei; Li, Yuanfang; Rothschild, Sacha I; Cai, Muyan.

Afiliação

Nie R; Department of Gastric Surgery, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China.
Chen F; Department of Radiology Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China.
Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Wang Y; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China.
van den Ende T; Amsterdam UMC, Department of Medical Oncology, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.
van Laarhoven HWM; Amsterdam UMC, Department of Medical Oncology, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.
Yuan S; Department of Gastric Surgery, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China.
Pless M; Department of Oncology, Cantonal Hospital Winterthur, Winterthur, Switzerland; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
Hayoz S; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland.
Zhou Z; Department of Gastric Surgery, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China.
Li Y; Department of Gastric Surgery, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China. Electronic address: liyuanf@sysucc.org.cn.
Rothschild SI; Department of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel, Basel, Switzerland; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland. Electronic address: sacha.rothschild@usb.ch.
Cai M; Department of Pathology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, PR China. Electronic address: caimy@sysucc.org.cn.

Eur J Cancer ; 186: 211-221, 2023 06.

Article em En | MEDLINE | ID: mdl-37062625

Assuntos

Inibidores de Checkpoint Imunológico; Terapia Neoadjuvante; Humanos; Biomarcadores; Modelos de Riscos Proporcionais; Imunoterapia

Palavras-chave

End-point; Immunotherapy; Neoadjuvant; Overall survival; Surrogate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante / Inibidores de Checkpoint Imunológico Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google